AROMATASE INHIBITORS IN THE TREATMENT OF BREAST-CANCER

被引:83
作者
BRODIE, AMH
机构
[1] Department of Pharmacology, Experimental Therapeutics, School of Medicine, Baltimore
关键词
D O I
10.1016/0960-0760(94)90269-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of inhibitors of estrogen synthesis are now becoming available which could be of value in the treatment of breast cancer. 4-Hydroxyandrostenedione (4-OHA), the first of these compounds to enter the clinic has been found to be effective in postmenopausal patients who have relapsed from tamoxifen. Thus, in studies of 240 patients, 26% patients experienced partial or complete response to treatment. An additional 25% patients had disease stabilization. 4-OHA is a potent selective, steroidal inhibitor which causes inactivation of aromatase in vitro. It is effective in reducing concentrations of ovarian estrogens in rats and of ovarian and peripheral estrogens in non-human primate species. The compound has been shown to lower serum estrogen levels in postmenopausal breast cancer patients. However, not all of these patients experienced disease remission, suggesting that their tumors were hormone insensitive rather than that the dose of 4-OHA was suboptimal. In trials of patients who had not received prior tamoxifen treatment, 4-OHA (250 mg i.m every 2 weeks) was found to induce complete or partial tumor regression in 33% of patients. The response of patients was not significantly different from that observed in patients treated with tamoxifen (30 mg o.d) of 37%. No significant difference between treatments was observed for disease stabilization, the duration of response or median survival. Several other steroidal aromatase inhibitors have been studied, such as 7 alpha-substituted androstenedione derivatives. MDL 18962 [10-(2-propynyl)estr-4-ene-3,17-dione] and FCE 24304 (6-methylen-androsta-1,4-diene-3,17-dione) are currently in clinical trials. Non-steroidal inhibitors of cytochrome P-450 enzymes, such as imidazole and triazole derivatives have been developed which are highly selective for aromatase. Three triazoles which are very potent and selective inhibitors are vorazole (6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)-methyl]1-methyl-1H-benzotriazole R 76713, arimidex 2,2'[5-(1H-1,2,4-triazol-1-yl methyl)-1,3-phenylene]bis(2-methylpropiononitrile) (ZD1033) and letrozole 4-[1-(cyanophenyl)-1-(1,2,4-triazolyl)methyl]benzonitril (CGS 20267). These compounds reduce serum estradiol concentration to undetectable levels in breast cancer patients. These highly potent inhibitors provide the opportunity to determine whether a further degree of estrogen suppression will be important in producing greater clinical response. With the recent approval of 4-OHA in several countries and the introduction of the potent new compounds, aromatase inhibitors either alone or in combination with the antiestrogen are likely to improve the treatment of breast cancer .
引用
收藏
页码:281 / 287
页数:7
相关论文
共 69 条
  • [1] MECHANISTIC STUDIES ON C-19 DEMETHYLATION IN ESTROGEN BIOSYNTHESIS
    AKHTAR, M
    CALDER, MR
    CORINA, DL
    WRIGHT, JN
    [J]. BIOCHEMICAL JOURNAL, 1982, 201 (03) : 569 - 580
  • [2] HIGHLY SELECTIVE-INHIBITION OF ESTROGEN BIOSYNTHESIS BY CGS-20267, A NEW NONSTEROIDAL AROMATASE INHIBITOR
    BHATNAGAR, AS
    HAUSLER, A
    SCHIEWECK, K
    LANG, M
    BOWMAN, R
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06) : 1021 - 1027
  • [3] INACTIVATION OF AROMATASE INVITRO BY 4-HYDROXY-4-ANDROSTENE-3, 17-DIONE AND 4-ACETOXY-4-ANDROSTENE-3, 17-DIONE AND SUSTAINED EFFECTS INVIVO
    BRODIE, AMH
    GARRETT, WM
    HENDRICKSON, JR
    TSAIMORRIS, CH
    MARCOTTE, PA
    ROBINSON, CH
    [J]. STEROIDS, 1981, 38 (06) : 693 - 702
  • [4] EFFECT OF AN AROMATASE INHIBITOR, 1,4,6-ANDROSTATRIENE-3,17-DIONE, ON 7,12-DIMETHYLBENZ (A) ANTHRACENE-INDUCED MAMMARY-TUMORS IN THE RAT AND ITS MECHANISM OF ACTION INVIVO
    BRODIE, AMH
    BRODIE, HJ
    GARRETT, WM
    HENDRICKSON, JR
    MARSH, DA
    TSAIMORRIS, CH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (11) : 2017 - 2023
  • [5] AROMATASE INHIBITORS .3. STUDIES ON ANTI-FERTILITY EFFECT OF 4-ACETOXY-4-ANDROSTENE-3,17-DIONE
    BRODIE, AMH
    WU, JT
    MARSH, DA
    BRODIE, HJ
    [J]. BIOLOGY OF REPRODUCTION, 1978, 18 (03) : 365 - 370
  • [6] STUDIES ON MECHANISM OF ESTROGEN BIOSYNTHESIS IN RAT OVARY .1.
    BRODIE, AMH
    SCHWARZEL, WC
    BRODIE, HJ
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1976, 7 (10) : 787 - 793
  • [7] BRUEGGEMEIER R W, 1987, Steroids, V50, P163, DOI 10.1016/0039-128X(83)90069-7
  • [8] BIOCHEMICAL AND PHARMACOLOGICAL DEVELOPMENT OF STEROIDAL INHIBITORS OF AROMATASE
    BRUEGGEMEIER, RW
    LI, PK
    CHEN, HH
    MOH, PP
    KATLIC, NE
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (03) : 379 - 385
  • [9] BRUGGEMEIER RW, 1993, J STEROID BIOCHEM, V44, P357
  • [10] HUMAN AROMATASE - CDNA CLONING, SOUTHERN BLOT ANALYSIS, AND ASSIGNMENT OF THE GENE TO CHROMOSOME-15
    CHEN, SU
    BESMAN, MJ
    SPARKES, RS
    ZOLLMAN, S
    KLISAK, I
    MOHANDAS, T
    HALL, PF
    SHIVELY, JE
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1988, 7 (01): : 27 - 38